Evidence map›Paper›PMID 36625766›Full record

ArticleACS applied materials & interfaces2023

Correction to "Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases".

Nuseibah Al Qtaish, Idoia Gallego, Alejandro J Paredes, Ilia Villate-Beitia, Cristina Soto-Sánchez, Gema Martínez-Navarrete, Myriam Sainz-Ramos, Tania B Lopez-Mendez, Francisco Javier Chichón, Noelia Zamarreño and 3 more

Abstract readPublished Erratum
In one paragraph

Article in ACS applied materials & interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Nuseibah Al QtaishNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-5966-6155
Idoia GallegoNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-9312-8147
Alejandro J ParedesResearch and Development Unit in Pharmaceutical Technology (UNITEFA), CONICET and Department of Pharmaceutical Sciences, Chemistry Sciences Faculty, National University of Córdoba, Haya de la Torre y Medina Allende, X5000XHUA Córdoba, Argentina.ORCID 0000-0002-0414-8972
Ilia Villate-BeitiaNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-3738-7611
Cristina Soto-SánchezNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-4447-5967
Gema Martínez-NavarreteNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-9795-2846
Myriam Sainz-RamosNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-7266-5771
Tania B Lopez-MendezNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0001-5029-6549
Francisco Javier ChichónCryoEM CSIC Facility, Structure of Macromolecules Department, Centro Nacional de Biotecnología (CNB-CSIC), Calle Darwin no. 3, 28049 Madrid, Spain.
Noelia ZamarreñoCryoEM CSIC Facility, Structure of Macromolecules Department, Centro Nacional de Biotecnología (CNB-CSIC), Calle Darwin no. 3, 28049 Madrid, Spain.
Eduardo FernándezNetworking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-7052-6011
Gustavo PurasNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-1536-7601
José Luis PedrazNanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-3938-2267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36625766
PMCPMC9880947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.